Chargement en cours...
Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
SUMMARY: Besides surgery, radiation, chemotherapy, and endocrine treatment, immunotherapy has become an established part of systemic therapy in treating metastatic breast cancer. One of the most interesting targets for the design of anticancer therapeutics is the HER2/ErbB2 receptor which is overexp...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931093/ https://ncbi.nlm.nih.gov/pubmed/20847829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285714 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|